Kursthemen
-
- Antibody glycosylation in inflammation, disease and vaccination
- Benefits of using heterologous polyclonal antibodies and potential applications to new and undertreated infectious pathogens _ Elsevier Enhanced Reader
- Environmental and Molecular Drivers of the alpha Gal Syndrome
- From therapeutic antibodies to immune complex vaccines
- History and practice antibodies in infectious diseases
- history of passive antibody administration
- IgG Fc Glycosylation in Human Immunity
- Immunoglobulin G glycosylation in aging and diseases
- Intravenous immunoglobulin therapy_ a snapshot for the internist
- Natural Antibodies from First-Line Defense Against Pathogens to Perpetual Immune Homeostasis
- Next-generation Fc receptor targeting biologics for autoimmune diseases _ Elsevier Enhanced Reader
- Passive Ab therapy for Infectious Diseases
- Understanding the role of antibody glycosylation through the lens of severe viral bacterial diseases
- Functional diversification of IgGs through Fc glycosylation